Stock Screener App

Frei -

Installieren

3.415

3.96% -0.145

Rocket Pharmaceuticals Inc (RCKT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	10.50% 71.15	64.39	69.42	73.71	67.38
Interest Income/Expense	0.21% 0.473	0.472	0.471	0.471	0.471
Operating Income/Loss	10.50% -71.15	-64.39	-69.42	-73.71	-67.38
Income/Loss From Continuing Operations Before Tax	12.37% -68.92	-61.33	-66.72	-69.65	-62.05
Income/Loss From Continuing Operations After Tax	12.37% -68.92	-61.33	-66.72	-69.65	-62.05
Net Income/Loss	12.37% -68.92	-61.33	-66.72	-69.65	-62.05
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.84% 111.02	110.09	94.16	93.75	93.55
Diluted Average Shares	0.84% 111.02	110.09	94.16	93.75	93.55
Basic Earnings Per Share	10.71% -0.62	-0.56	-0.71	-0.74	-0.66
Diluted Earnings Per Share	10.71% -0.62	-0.56	-0.71	-0.74	-0.66
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.88

1.49%

GMAB

$29.28

1.93%

INCY

$103.10

1.51%

BNTX

$104.49

0.38%

ONC

$315.07

1.04%

INSM

$185.94

0.29%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters